Adagene Inc is a biopharmaceutical company focusing on monoclonal antibody drugs for cancers in the clinical stage. The company's product candidates include ADG106, ADG126, ADG116, ADG104, ADG125, ADG206, ADG153, ADG138, and ADG152. The company was founded in 2011 and is located in Suzhou, China.